Russell Investments Group’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$788K Sell
125,493
-163,567
-57% -$1.52M ﹤0.01% 2324
2025
Q4
$3.54M Buy
289,060
+75,762
+36% +$1.24M ﹤0.01% 1538
2025
Q3
$4.37M Buy
213,298
+102,688
+93% +$1.63M 0.01% 1393
2025
Q2
$1.49M Buy
110,610
+64,790
+141% +$709K ﹤0.01% 1871
2025
Q1
$397K Buy
45,820
+45,640
+25,356% +$279K ﹤0.01% 2374
2024
Q4
$875 Buy
180
+160
+800% +$894 ﹤0.01% 3544
2024
Q3
$154 Sell
20
-11
-35% -$98 ﹤0.01% 3657
2024
Q2
$310 Hold
31
﹤0.01% 3530
2024
Q1
$377 Hold
31
﹤0.01% 3242
2023
Q4
$444 Buy
+31
New +$297 ﹤0.01% 3131
2023
Q3
Sell
-6,184
Closed -$88.4K 3597
2023
Q2
$88.4K Sell
6,184
-53,022
-90% -$755K ﹤0.01% 2628
2023
Q1
$866K Buy
59,206
+34,827
+143% +$583K ﹤0.01% 2043
2022
Q4
$410K Buy
+24,379
New +$422K ﹤0.01% 2345
2022
Q3
Sell
-147,534
Closed -$4.04M 2952
2022
Q2
$4.04M Buy
147,534
+84,322
+133% +$2.5M 0.01% 1205
2022
Q1
$2.38M Buy
63,212
+2,950
+5% +$131K ﹤0.01% 1555
2021
Q4
$3.74M Sell
60,262
-22,672
-27% -$1.72M 0.01% 1433
2021
Q3
$7.09M Buy
82,934
+27,106
+49% +$1.7M 0.01% 1056
2021
Q2
$3.45M Sell
55,828
-21,224
-28% -$1.08M 0.01% 1583
2021
Q1
$3.75M Buy
77,052
+26,050
+51% +$1.26M 0.01% 1512
2020
Q4
$1.59M Buy
51,002
+9,355
+22% +$229K ﹤0.01% 1877
2020
Q3
$867K Buy
+41,647
New +$715K ﹤0.01% 2140
2020
Q1
Sell
-96,741
Closed -$991K 3106
2019
Q4
$991K Sell
96,741
-102,472
-51% -$1.16M ﹤0.01% 2104
2019
Q3
$2.88M Sell
199,213
-56,083
-22% -$868K 0.01% 1491
2019
Q2
$4.13M Sell
255,296
-23,795
-9% -$321K 0.01% 1325
2019
Q1
$3.55M Buy
279,091
+96,082
+53% +$1.25M 0.01% 1419
2018
Q4
$2M Buy
183,009
+97,727
+115% +$1.45M ﹤0.01% 1612
2018
Q3
$1.53M Buy
+85,282
New +$1.07M ﹤0.01% 1887

Other funds holding OPRX

Russell Investments Group's OPRX Position: Q1 2026 in Review

Russell Investments Group reduced its OptimizeRx (OPRX) stake by 57% in Q1 2026, selling an estimated $1.52M and leaving 125,493 shares worth $788K. The position accounts for ﹤0.01% of the portfolio, ranked #2324.

Russell Investments Group first reported a position in OPRX in Q3 2018 and has held it in 27 quarters since. The position peaked at $7.09M in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Russell Investments Group held 125,493 shares of OptimizeRx worth $788K as of Q1 2026.
  • Russell Investments Group sold 163,567 OptimizeRx shares in Q1 2026, an estimated $1.52M.
  • OptimizeRx made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2324 holding.
  • Russell Investments Group first reported a position in OptimizeRx in Q3 2018 and has held it in 27 quarters since.
  • Russell Investments Group's OptimizeRx position peaked at $7.09M in Q3 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.